Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

3.010 +0.240 (+8.66%)
Streaming Delayed Price Updated: 9:51 AM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,699,643
Open 2.380
Bid (Size) 2.960 (100)
Ask (Size) 3.010 (200)
Prev. Close 2.770
Today's Range 2.380 - 3.010
52wk Range 0.5200 - 5.920
Shares Outstanding 66,113,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tuesday's pre-market session: top gainers and losers
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss
Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss. 
Via Chartmill

Performance

YTD
+102.0%
+102.0%
1 Month
+6.4%
+6.4%
3 Month
-35.4%
-35.4%
6 Month
-33.1%
-33.1%
1 Year
+176.1%
+176.1%

More News

Read More
Earnings Scheduled For November 4, 2025
Via Benzinga
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
From Neuronetics
Via GlobeNewswire
Earnings Scheduled For August 5, 2025
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
From Neuronetics
Via GlobeNewswire
Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss
Via Chartmill
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
From Neuronetics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
From Neuronetics
Via GlobeNewswire
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
From Neuronetics
Via GlobeNewswire
Earnings Scheduled For March 4, 2025
Via Benzinga
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression
From Neuronetics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
From Neuronetics
Via GlobeNewswire
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
From Neuronetics
Via GlobeNewswire
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
From Neuronetics
Via GlobeNewswire
NeuroStar® Releases Software Upgrades to Elevate Patient Care
From Neuronetics
Via GlobeNewswire

Frequently Asked Questions

Is Neuronetics, Inc. - Common Stock publicly traded?
Yes, Neuronetics, Inc. - Common Stock is publicly traded.
What exchange does Neuronetics, Inc. - Common Stock trade on?
Neuronetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neuronetics, Inc. - Common Stock?
The ticker symbol for Neuronetics, Inc. - Common Stock is STIM on the Nasdaq Stock Market
What is the current price of Neuronetics, Inc. - Common Stock?
The current price of Neuronetics, Inc. - Common Stock is 3.010
When was Neuronetics, Inc. - Common Stock last traded?
The last trade of Neuronetics, Inc. - Common Stock was at 11/04/25 09:51 AM ET
What is the market capitalization of Neuronetics, Inc. - Common Stock?
The market capitalization of Neuronetics, Inc. - Common Stock is 199.00M
How many shares of Neuronetics, Inc. - Common Stock are outstanding?
Neuronetics, Inc. - Common Stock has 199M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.